Global Pharmaceuticals Company Receives FDA Approval For Parkinson's Disease Treatment

FDA Approves CREXONT® (Carbidopa and Levodopa) Extended-Release Capsules for Parkinson's Disease: A New Horizon in Treatment.

Created with TradingView

Disclaimer: The following article is for informational purposes only and does not constitute medical advice. Always consult with a healthcare professional for medical concerns and treatment options.

Real-time information is available daily at https://stockregion.net